These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28263048)

  • 21. Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database.
    Pratley RE; Schweizer A; Rosenstock J; Foley JE; Banerji MA; Pi-Sunyer FX; Mills D; Dejager S
    Diabetes Obes Metab; 2008 Sep; 10(10):931-8. PubMed ID: 18093207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of glucagon on islet beta cell function in patients with diabetes mellitus.
    Wang T; Xiao XH; Li WH; Wang H; Sun Q; Yuan T; Yang GH
    Chin Med Sci J; 2008 Jun; 23(2):117-20. PubMed ID: 18686632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2.
    Lee WJ; Chong K; Chen CY; Chen SC; Lee YC; Ser KH; Chuang LM
    Obes Surg; 2011 Jul; 21(7):889-95. PubMed ID: 21499957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of beta-cell function in young patients with type 2 diabetes: arginine-stimulated insulin secretion may reflect beta-cell reserve.
    Sjostrand M; Carlson K; Arnqvist HJ; Gudbjörnsdottir S; Landin-Olsson M; Lindmark S; Nyström L; Svensson MK; Eriksson JW; Bolinder J
    J Intern Med; 2014 Jan; 275(1):39-48. PubMed ID: 24482829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes.
    Subauste A; Gianani R; Chang AM; Plunkett C; Pietropaolo SL; Zhang YJ; Barinas-Mitchell E; Kuller LH; Galecki A; Halter JB; Pietropaolo M
    PLoS One; 2014; 9(9):e106537. PubMed ID: 25226365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ileal interposition reduces blood glucose levels and decreases insulin resistance in a type 2 diabetes mellitus animal model by up-regulating glucagon-like peptide-1 and its receptor.
    Sun X; Zheng M; Song M; Bai R; Cheng S; Xing Y; Yuan H; Wang P
    Int J Clin Exp Pathol; 2014; 7(7):4136-42. PubMed ID: 25120793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term Metabolic Outcomes of Functioning Pancreas Transplants in Type 2 Diabetic Recipients.
    Shin S; Jung CH; Choi JY; Kwon HW; Jung JH; Kim YH; Han DJ
    Transplantation; 2017 Jun; 101(6):1254-1260. PubMed ID: 27336397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.
    Mari A; Del Prato S; Ludvik B; Milicevic Z; de la Peña A; Shurzinske L; Karanikas CA; Pechtner V
    Diabetes Obes Metab; 2016 Aug; 18(8):834-9. PubMed ID: 27059816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Predictors of Type 2 Diabetes Mellitus Remission After Roux-en-Y Gastric Bypass in 101 Chinese Patients.
    Yan W; Bai R; Li Y; Xu J; Zhong Z; Xing Y; Yan M; Lin Y; Song M
    Obes Surg; 2019 Jun; 29(6):1867-1873. PubMed ID: 30798440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion.
    Adami GF; Camerini G; Papadia F; Catalano MF; Carlini F; Cordera R; Scopinaro N
    Obes Surg; 2019 Jan; 29(1):239-245. PubMed ID: 30232725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of metabolic surgery in obese patients with type 2 diabetes with respect to impact on beta cell function, insulin sensitivity and diabetes remission - A study from south India.
    Chandru S; Pramodkumar TA; Pradeepa R; Muthukumar S; Balasubramanyam M; Bhuvaneshwari R; Anjana RM; Mohan V
    Diabetes Metab Syndr; 2020; 14(6):1829-1835. PubMed ID: 32961515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of glucagon response on early postprandial glucose excursions irrespective of residual β-cell function in type 1 diabetes: A cross-sectional study using a mixed meal tolerance test.
    Ito A; Horie I; Miwa M; Sako A; Niri T; Nakashima Y; Shigeno R; Haraguchi A; Natsuda S; Akazawa S; Kamada A; Kawakami A; Abiru N
    J Diabetes Investig; 2021 Aug; 12(8):1367-1376. PubMed ID: 33369175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency.
    Ciresi A; Cicciò F; Radellini S; Giordano C
    Growth Horm IGF Res; 2016 Aug; 29():71-77. PubMed ID: 27235725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple defects in counterregulation of hypoglycemia in modestly advanced type 2 diabetes mellitus.
    Israelian Z; Szoke E; Woerle J; Bokhari S; Schorr M; Schwenke DC; Cryer PE; Gerich JE; Meyer C
    Metabolism; 2006 May; 55(5):593-8. PubMed ID: 16631434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients.
    Nauck MA; Weber I; Bach I; Richter S; Orskov C; Holst JJ; Schmiegel W
    Diabet Med; 1998 Nov; 15(11):937-45. PubMed ID: 9827848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incretins in fibrocalculous pancreatic diabetes: A unique subtype of pancreatogenic diabetes.
    Ghosh I; Mukhopadhyay P; Das K; Anne M B; Ali Mondal S; Basu M; Nargis T; Pandit K; Chakrabarti P; Ghosh S
    J Diabetes; 2021 Jun; 13(6):506-511. PubMed ID: 33247879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative Beta Cell Function Is Predictive of Diabetes Remission After Bariatric Surgery.
    Souteiro P; Belo S; Neves JS; Magalhães D; Silva RB; Oliveira SC; Costa MM; Saavedra A; Oliveira J; Cunha F; Lau E; Esteves C; Freitas P; Varela A; Queirós J; Carvalho D
    Obes Surg; 2017 Feb; 27(2):288-294. PubMed ID: 27435450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of sitagliptin or metformin to insulin monotherapy improves blood glucose control via different effects on insulin and glucagon secretion in hyperglycemic Japanese patients with type 2 diabetes.
    Otsuka Y; Yamaguchi S; Furukawa A; Kosuda M; Nakazaki M; Ishihara H
    Endocr J; 2015; 62(2):133-43. PubMed ID: 25328079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric bypass procedure for type 2 diabetes patients with BMI <28 kg/m
    Gong K; Li K; Zhang N; Zhu B; Du D; Zhang D; Zhang Z; Peng J
    Surg Endosc; 2017 Mar; 31(3):1172-1179. PubMed ID: 27422245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
    Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
    Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.